Here's how they compare: Semaglutide (GLP-1 agonist) Mechanism: Single-action GLP-1 receptor agonist FDA status: Approved for type 2 diabetes and chronic weight management Expected weight loss: 15-20% of body weight in clinical trials Administration: Once-weekly injection Best for: Patients starting their weight loss journey seeking proven, well-studied medication Tirzepatide (dual GIP/GLP-1 agonist) Mechanism: Targets both GIP and GLP-1 receptors for enhanced metabolic effect FDA status: Approved for type 2 diabetes and chronic weight management Expected weight loss: Up to 22% of body weight in clinical trials Administration: Once-weekly injection Best for: Patients seeking more aggressive fat loss with dual-action metabolic support Retatrutide (triple agonist, not yet available) Mechanism: Targets GLP-1, GIP, and glucagon receptors FDA status: Not FDA-approved

Key Takeaway: Compounded semaglutide is a personalized medication prepared by licensed pharmacists to match a specific prescription, helping individuals manage appetite and support metabolic health
Medical disclaimer: This post reflects my personal experience and is not medical advice
The Cons and Cautions of Semaglutide Image Source: Miami Bariatric and Plastic Surgery MD Understanding potential drawbacks remains essential when considering semaglutide treatment
In particular, patients should regularly use exercises such as weight-lifting and resistance training, says Abelovska
Melanin in our bodies is responsible for giving pigment to our skin